These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12953623)

  • 1. The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis.
    Baumeister AA; Hawkins MF; Uzelac SM
    J Hist Neurosci; 2003 Jun; 12(2):207-20. PubMed ID: 12953623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine theories of depression: historical impact on biomedical research.
    Mulinari S
    J Hist Neurosci; 2012; 21(4):366-92. PubMed ID: 22947380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chlorpromazine enigma.
    Baumeister AA
    J Hist Neurosci; 2013; 22(1):14-29. PubMed ID: 23323529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM
    J Clin Psychiatry; 2000; 61 Suppl 6():4-6. PubMed ID: 10775017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prejudices in pharmacology and pharmacotherapy: reserpine as a model for experimental research in depression.
    Bein HJ
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Nov; 11(6):289-93. PubMed ID: 368819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine system disruption induces functional somatic syndromes associated symptomatology in mice.
    Nagakura Y; Ohsaka N; Azuma R; Takahashi S; Takebayashi Y; Kawasaki S; Murai S; Miwa M; Saito H
    Physiol Behav; 2018 Oct; 194():505-514. PubMed ID: 29981307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Milestones of cardiovascular therapy. IV. Reserpine].
    Jerie P
    Cas Lek Cesk; 2007; 146(7):573-7. PubMed ID: 17722843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invited review: the evolution of antidepressant mechanisms.
    Slattery DA; Hudson AL; Nutt DJ
    Fundam Clin Pharmacol; 2004 Feb; 18(1):1-21. PubMed ID: 14748749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of reserpine on depression: A systematic review.
    Strawbridge R; Javed RR; Cave J; Jauhar S; Young AH
    J Psychopharmacol; 2023 Mar; 37(3):248-260. PubMed ID: 36000248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of antipsychotic drug therapy: reserpine, chlorpromazine, and haloperidol.
    Preskorn SH
    J Psychiatr Pract; 2007 Jul; 13(4):253-7. PubMed ID: 17667738
    [No Abstract]   [Full Text] [Related]  

  • 11. Attempts to validate melancholic depression: some observations on modern research methodology.
    Rasmussen KG
    Bull Menninger Clin; 2007; 71(2):150-63. PubMed ID: 17666004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Historical approach to reserpine discovery and its introduction in psychiatry].
    López-Muñoz F; Bhatara VS; Alamo C; Cuenca E
    Actas Esp Psiquiatr; 2004; 32(6):387-95. PubMed ID: 15529229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of drug research to investigating the nature of endogenous depression.
    Carlsson A
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):2-10. PubMed ID: 10584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of nerve growth factor biosynthesis in developing rat brain by reserpine: steroids as potential mediators.
    Fabrazzo M; Costa E; Mocchetti I
    Mol Pharmacol; 1991 Feb; 39(2):144-9. PubMed ID: 1996081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress of monoaminergic receptor investigation on depression].
    Gao XF; Wang XQ; He C; Lu CL
    Sheng Li Ke Xue Jin Zhan; 2002 Jan; 33(1):17-20. PubMed ID: 12001723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoamine research--a productive field of particular importance in neuroscience].
    Carlsson A
    Lakartidningen; 1990 Nov; 87(45):3764, 3767-9. PubMed ID: 1977976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of depression psychopharmacology.
    Belmaker RH
    CNS Spectr; 2008 Aug; 13(8):682-7. PubMed ID: 18704023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical development of the dopamine hypothesis of schizophrenia.
    Baumeister AA; Francis JL
    J Hist Neurosci; 2002 Sep; 11(3):265-77. PubMed ID: 12481477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The concept of depression--its historical development].
    Grecu G; Pirozynski T; Grecu-Gaboş M; Chiriţă V; Grecu-Gaboş I
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(3-4):495-501. PubMed ID: 2131540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
    Martin-Iverson MT; Yamada N; By AW; Lodge BA
    J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.